Our reports
- About us
- Our work
- In the news
- Monthly news round-up
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- August 2008
- July 2008
- June 2008
- May 2008
- Monthly news round-up
- Resources
- Events
- Contact us
- Support us
- What's new
- Search
Dr Mark Kroese
View all authors | Go to profile pageList of publications, news articles and reports by this author.
View profile
-
Alberg C, Burton H, Whittaker J, Kroese M, Lakshman R. A framework for the prioritization of investment in the provision of genetic tests. Public Health Genomics. 2010 Mar 15 [Epub ahead of print]
-
Burke W, Zimmern R, Kroese M. Defining purpose: a key step in genetic test evaluation. Genetics in Medicine. 2007 9(10):675-681
-
Kroese M, Zimmern R, Pinder S. HER2 status in breast cancer - an example of pharmacogenetic testing. Journal of the Royal Society of Medicine. 2007 Jul;100(7):326-9Go to Entrez PubMed reference (full text access requires subscription to journal)
-
Kroese M, Zimmern R. The evaluation of genetic tests. Journal of Public Health. 2007 May 24; [Epub ahead of print]
-
Higgins J, Sanderson S, Zimmern R, Kroese M, Patch C, Emery J. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine. 2005;7(7):495-500
-
Kroese M, Zimmern R. Genetic tests and their evaluation: Can we answer the key questions? Genetics in Medicine. 2004;6(6):475-80